Publication | Closed Access

Antimicrobial activity-specific to Gram-negative bacteria and immune modulation-mediated NF-κB and Sp1 of a medaka β-defensin

Medical MicrobiologyAntibioticsMedicineImmunologyAntimicrobial ChemotherapyGram-negative BacteriaMedaka β-DefensinAntibacterial AgentAntimicrobial TherapyMicrobiologyAntimicrobial AgentsInfection ControlImmune Modulation-mediated Nf-κbBacterial PathogensHost-microbe InteractionClinical MicrobiologyAntimicrobial ResistanceAntimicrobial Compound